ES2193192T3 - Receptores de interleuquina-15. - Google Patents

Receptores de interleuquina-15.

Info

Publication number
ES2193192T3
ES2193192T3 ES95918389T ES95918389T ES2193192T3 ES 2193192 T3 ES2193192 T3 ES 2193192T3 ES 95918389 T ES95918389 T ES 95918389T ES 95918389 T ES95918389 T ES 95918389T ES 2193192 T3 ES2193192 T3 ES 2193192T3
Authority
ES
Spain
Prior art keywords
interleuquine
receivers
il15r
adns
recombinating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918389T
Other languages
English (en)
Inventor
Dirk M Anderson
Judith G Giri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ES2193192T3 publication Critical patent/ES2193192T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE DESCRIBEN PROTEINAS DEL RECEPTOR DE LA INTERLEUQUINA-15 (IL15R), ADNS Y VECTORES DE EXPRESION QUE CODIFICAN LA IL-15R, Y PROCESOS PARA LA PRODUCCION DE IL-15R COMO PRODUCTOS DE CULTIVOS DE CELULAS RECOMBINANTES.
ES95918389T 1994-05-06 1995-05-04 Receptores de interleuquina-15. Expired - Lifetime ES2193192T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23691994A 1994-05-06 1994-05-06
US08/300,903 US5591630A (en) 1994-05-06 1994-09-06 Monoclonal antibodies that bind interleukin-15 receptors

Publications (1)

Publication Number Publication Date
ES2193192T3 true ES2193192T3 (es) 2003-11-01

Family

ID=26930223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918389T Expired - Lifetime ES2193192T3 (es) 1994-05-06 1995-05-04 Receptores de interleuquina-15.

Country Status (11)

Country Link
US (1) US5591630A (es)
EP (1) EP0759942B1 (es)
AT (1) ATE233788T1 (es)
AU (1) AU695798B2 (es)
CA (1) CA2188279C (es)
DE (1) DE69529822T2 (es)
DK (1) DK0759942T3 (es)
ES (1) ES2193192T3 (es)
NZ (1) NZ285292A (es)
PT (1) PT759942E (es)
WO (1) WO1995030695A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548065B1 (en) * 1994-05-06 2003-04-15 Immunex Corporation Interleukin-15 receptors
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
DK0932417T3 (da) 1996-10-17 2003-04-14 Immunomedics Inc Non-antigent toxinkonjugat og fusionsprotein af internaliserende receptorsystem
US6344192B1 (en) * 1997-02-21 2002-02-05 Vlaams Interuniversitair Instituut Voor Biotechnologie Use of interleukin-15
AU5093899A (en) * 1998-07-07 2000-01-24 Hisamitsu Pharmaceutical Co. Inc. Antisense oligonucleotides targeted to il-15
EP1265912A4 (en) * 2000-03-03 2004-07-28 Univ Utah Res Found GEN GEN1 AS A TARGET FOR THE DEVELOPMENT OF ANTICONVULSIVE MEDICINES
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
US7153507B2 (en) * 2001-08-23 2006-12-26 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
NZ581779A (en) 2005-05-17 2011-09-30 Univ Connecticut Composition and methods for immunomodulation in an organism comprising interleukin-15 polypeptide and interleukin-15 receptor subunit A polypeptide complex
EP1777294A1 (en) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
BRPI0707106B1 (pt) 2006-01-13 2022-06-07 The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Polinucleotídeo interleucina-15, vetor de expressão, e, composição farmacêutica
JP2010531878A (ja) 2007-06-27 2010-09-30 マリン ポリマー テクノロジーズ，インコーポレーテッド ＩＬ‐１５とＩＬ‐１５Ｒαとの複合体及びその使用
US8871191B2 (en) 2009-08-14 2014-10-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of IL-15 preparations to treat lymphopenia
WO2011031986A1 (en) 2009-09-10 2011-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Assays for soluble il-15 receptor alpha
MX365527B (es) 2012-10-24 2019-06-06 Us Health Formas il-15r alfa, celulas que expresan las formas de il-15 alfa, y usos terapeuticos de il-15r alfa y complejos il-15/il-15r.
ES2906615T3 (es) 2013-04-19 2022-04-19 Cytune Pharma Tratamiento derivado de citocinas con síndrome de fuga vascular reducido
WO2016018920A1 (en) 2014-07-29 2016-02-04 Admune Therapeutics Llc Il-15 and il-15ralpha heterodimer dose escalation regimens for treating conditions
CN109715196A (zh) 2016-06-13 2019-05-03 转矩医疗股份有限公司 用于促进免疫细胞功能的组合物和方法
AU2018328209A1 (en) 2017-09-05 2020-04-23 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
CN112795543B (zh) * 2021-02-04 2022-09-27 华中农业大学 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用
WO2024040132A2 (en) 2022-08-16 2024-02-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic Synergistic interactions for improved cancer treatment

Also Published As

Publication number Publication date
AU2434495A (en) 1995-11-29
EP0759942B1 (en) 2003-03-05
CA2188279C (en) 2010-01-26
EP0759942A1 (en) 1997-03-05
WO1995030695A1 (en) 1995-11-16
DK0759942T3 (da) 2003-06-10
ATE233788T1 (de) 2003-03-15
NZ285292A (en) 1998-08-26
PT759942E (pt) 2003-07-31
AU695798B2 (en) 1998-08-20
DE69529822D1 (de) 2003-04-10
EP0759942A4 (en) 1999-05-12
US5591630A (en) 1997-01-07
DE69529822T2 (de) 2003-12-11
CA2188279A1 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
ES2193192T3 (es) Receptores de interleuquina-15.
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
DE69739366D1 (de) Aktive und inactive CC-Chemokinrezeptoren und Nukleinsäuremoleküle, die für diesen Rezeptor kodieren
ATE369346T1 (de) Halogenpyrimidinylaryl(thio)ether als pestizide
DE69426033T2 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
DE3586697D1 (en) Aktive thymopentin-analoga.
DE69413039D1 (de) Prostaglandin rezeptor fp und kodierende dns
ES2125864T3 (es) Vectores bacterianos.
DK0952853T3 (da) Konjugat omfattende et aktivt middel, et polypeptid og en polyether
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
ES2061787T3 (es) Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
MX9307007A (es) Vectores de expresion para tripsina y tripsinogeno de bovino y celulashuesped transformadoras con los mismos.
ES2175246T3 (es) Reticulante pobre en reversion.
PT80221B (en) Improved process for preparing benzamide derivatives useful as anticonvulsant agents
DE69428909D1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
ES2193399T3 (es) Derivados del acido nodulisporico.
ES2136199T3 (es) Expresion multicistronica de genes recombinantes en celulas bacterianas.
ES2059401T3 (es) Procedimiento microbiologico para la obtencion de una proteina mediante cultivo de una cepa bacteriana mutante.
DE59712385D1 (de) Cathepsin-l, dessen präproform und das entsprechende propeptid aus ciliaten
ES2191785T3 (es) Proteina de accion antitumoral.
ES2157386T3 (es) Procedimiento para la obtencion de 2-amino-6-clorofenil-isopropilsulfano.